TGS


MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome

MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome

https://www.gov.uk/government/news/mhra-approves-olezarsen-tryngolza-for-the-treatment-of-familial-chylomicronemia-syndrome

seen at 17:35, 10 April in News and communications.